Phase Genomics
Phase Genomics provides ultra-long-range genome sequencing technology and computational tools for researchers in genomics, cytogenetics, oncology, and microbiology. Its products enable genomic profiling, metagenome deconvolution, viral genome reconstruction, and detection of chromosomal abnormalities in a variety of organisms. The organization aims to empower scientists with advanced genomic tools to accelerate discoveries in health, agriculture, and environmental research.
Facts
- HQ
- Seattle, WA 98109
- Sectors
- Biotechnology Research
- Founded
- 2015
- Type
- Corporation Seattle business license
- Employees
- 15
- Registered name
- Phase Genomics Inc Seattle business license
- Stage
- startup
- Members see funding amounts. .
- Founders
- Ivan Liachko, Jay Shendure, PhD, Maitreya Dunham, PhD
Is this your organization? Claim it
Phase Genomics Announces ProxiMeta™ Starter and Elite Bundles, Cites Grants, Awards, and Funding Rounds Supporting Hi-C Metagenomics
Phase Genomics highlights recent milestones and coverage about its Hi-C genome-resolved metagenomics technology, including new product bundles, multiple grants and funding rounds, awards, leadership moves, and applications reported in scientific and popular media.
People
-
Ivan Liachko Founder & CEO
-
Kayla Young Executive, Executive Officer, COO